IBO vs KEY · rev $18.0K vs P/E 13, rev $7.51B
Impact BioMedical, Inc. (IBO) versus KeyCorp (KEY) — a side-by-side from cached financials, not a winner call.
Impact BioMedical, Inc. (IBO) is a biotechnology company listed on US.
KeyCorp (KEY) is a banks - regional company listed on US.
Latest reported IBO revenue for 2025-09-30 was $18.0K. Net income was -$1.5M. IBO currently screens at market cap $7.6M.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
IBO currently screens at market cap $7.6M. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Not investment advice. Open the IBO and KEY stock pages for the full models.
Not investment advice.